Literature DB >> 3653230

Prescribing digoxin in geriatric units: the unexplained variability in dosage requirements.

R J Dobbs1, J P Royston, C J O'Neill, A A Deshmukh, P W Nicholson, M J Denham, S M Dobbs.   

Abstract

Some physicians regard patients of Geriatric Units as a homogeneous population with respect to digoxin dosage requirements. Others advocate the use of pharmacokinetic models in prescribing digoxin for the elderly. Sixty in-patients of Geriatric Units were studied and the results compared with those previously obtained from 129 patients of other adult Units; all were receiving maintenance digoxin. For each patient the dose required to achieve a mean steady-state serum digoxin concentration of 1.6 nmol X l-1, the standardized dose, was calculated, assuming proportionality between the dose given and the concentration achieved. A mean of four estimates of standardized dose for each individual was used in the analysis. Threefold ranges of standardized dose covered the requirements of approximately 85% of patients both of Geriatric Units (62.5 to 187.5 micrograms per day) and of other adult Units (125 to 375 micrograms per day). The variables, serum creatinine concentration, sex, age, and body weight were of relatively little value in predicting the standardized dose for the patients in Geriatric Units. There was a sub-group of these in-patients for whom the standardized dose was extremely large.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3653230     DOI: 10.1007/BF02455997

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Steady-state kinetics of digoxin in the elderly.

Authors:  M A Roberts; F I Caird
Journal:  Age Ageing       Date:  1976-11       Impact factor: 10.668

2.  Digoxin: linearity between dose and serum concentration.

Authors:  S M Dobbs; J Parkes; E M Rodgers
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

3.  Differential effects of digoxin at comparable concentrations in tissues of fetal and adult sheep.

Authors:  W Berman; P J Ravenscroft; L B Sheiner; M A Heymann; K L Melmon; A M Rudolph
Journal:  Circ Res       Date:  1977-11       Impact factor: 17.367

4.  Active transport of L-dopa in the intestine.

Authors:  D N Wade; P T Mearrick; J L Morris
Journal:  Nature       Date:  1973-04-13       Impact factor: 49.962

5.  Plasma digoxin concentration--its relation to digoxin dosage and clinical effects in patients with atrial fibrillation.

Authors:  A Redfors
Journal:  Br Heart J       Date:  1972-04

6.  Serum digoxin determination in outpatients--need for standardization.

Authors:  T Jogestrand; R Nordlander
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

7.  Ideal sampling time for drug assays.

Authors:  P W Nicholson; S M Dobbs; E M Rodgers
Journal:  Br J Clin Pharmacol       Date:  1980-05       Impact factor: 4.335

8.  Blood levels of drug at the equilibrium state after multiple dosing.

Authors:  J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

9.  Age dependence of myocardial Na+-K+-ATPase activity and digitalis intoxication in the dog and guinea pig.

Authors:  A J Marsh; B L Lloyd; R R Taylor
Journal:  Circ Res       Date:  1981-03       Impact factor: 17.367

10.  A score for prescribing digoxin.

Authors:  P W Nicholson; S M Dobbs; A P McGill; E M Rodgers; E Slater
Journal:  Br Heart J       Date:  1978-02
View more
  6 in total

Review 1.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

2.  Evaluation of the safety of enalapril in the treatment of heart failure in the very old.

Authors:  C J O'Neill; S G Bowes; C M Sullens; J P Royston; W B Hunt; M J Denham; R J Dobbs; S M Dobbs
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Serum digoxin and beta-methyldigoxin in elderly patients on hospital admission: correlation with home compliance and clinical variables.

Authors:  G Seghieri; G C Bartolomei; L A De Giorgio; F Innocenti; A Gironi; M Mian; F Franconi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 4.  Digoxin toxicity in the aged. Characterising and avoiding the problem.

Authors:  A P Passmore; G D Johnston
Journal:  Drugs Aging       Date:  1991 Sep-Oct       Impact factor: 3.923

5.  Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patients.

Authors:  C J O'Neill; A Charlett; R J Dobbs; A A Deshmukh; S G Bowes; C Weller; P W Nicholson; J S Milledge; S M Dobbs
Journal:  Br J Clin Pharmacol       Date:  1992-02       Impact factor: 4.335

Review 6.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.